This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Second Opinion: Discussing the standard of care and the potential of the two updated Covid-19 booster shots from Pfizer/BioNTech and Moderna for this fall season
Ticker(s): PFE, MRNAWho's the expert?
Institution: NP Telehealth
- Primary Care/Internal Medicine physician practicing since 2011 in clinics and home visits.
- Supervises NPs and PAs that administer COVID boosters to patients at the clinic ~60+ this year, but in past years was more.
- 3 years research experience with first-authored publications, Board certified by the American Board of General Practice and American Board of UrgentCare Medicine.
Interview GoalThis call will focus on Pfizer-BioNTech and Moderna's updated mRNA Covid-19 shots the FDA recently cleared
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
